New Ray Medicine International Holding Past Earnings Performance
Past criteria checks 0/6
New Ray Medicine International Holding's earnings have been declining at an average annual rate of -23%, while the Healthcare industry saw earnings growing at 3.4% annually. Revenues have been declining at an average rate of 17.7% per year.
Key information
-23.0%
Earnings growth rate
-23.0%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | -17.7% |
| Return on equity | -4.6% |
| Net Margin | -44.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Lacklustre Performance Is Driving New Ray Medicine International Holding Limited's (HKG:6108) 34% Price Drop
Jan 26
There's Reason For Concern Over New Ray Medicine International Holding Limited's (HKG:6108) Price
Jun 08We're Keeping An Eye On New Ray Medicine International Holding's (HKG:6108) Cash Burn Rate
Mar 29
Revenue & Expenses Breakdown
How New Ray Medicine International Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 50 | -22 | 33 | 0 |
| 30 Sep 23 | 77 | -46 | 35 | 0 |
| 30 Jun 23 | 104 | -70 | 32 | 0 |
| 31 Mar 23 | 97 | -74 | 35 | 0 |
| 31 Dec 22 | 90 | -78 | 44 | 0 |
| 30 Sep 22 | 135 | -52 | 42 | 0 |
| 30 Jun 22 | 180 | -25 | 39 | 0 |
| 31 Mar 22 | 258 | -14 | 37 | 0 |
| 31 Dec 21 | 335 | -3 | 36 | 0 |
| 30 Sep 21 | 307 | -17 | 46 | 0 |
| 30 Jun 21 | 278 | -32 | 57 | 0 |
| 31 Mar 21 | 206 | -51 | 56 | 0 |
| 31 Dec 20 | 133 | -70 | 56 | 0 |
| 30 Sep 20 | 133 | -71 | 51 | 0 |
| 30 Jun 20 | 133 | -73 | 46 | 0 |
| 31 Mar 20 | 126 | -58 | 46 | 0 |
| 31 Dec 19 | 119 | -44 | 46 | 0 |
| 30 Sep 19 | 188 | -16 | 46 | 0 |
| 30 Jun 19 | 258 | 11 | 46 | 0 |
| 31 Mar 19 | 315 | 22 | 46 | 0 |
| 31 Dec 18 | 372 | 33 | 47 | 0 |
| 30 Sep 18 | 326 | -3 | 45 | 0 |
| 30 Jun 18 | 280 | -38 | 44 | 0 |
| 31 Mar 18 | 258 | -72 | 44 | 0 |
| 31 Dec 17 | 235 | -105 | 43 | 0 |
| 30 Sep 17 | 241 | -89 | 43 | 0 |
| 30 Jun 17 | 247 | -72 | 43 | 0 |
| 31 Mar 17 | 236 | -46 | 42 | 0 |
| 31 Dec 16 | 225 | -20 | 41 | 0 |
| 30 Sep 16 | 226 | -11 | 39 | 0 |
| 30 Jun 16 | 227 | -1 | 36 | 0 |
| 31 Mar 16 | 250 | 7 | 38 | 0 |
| 31 Dec 15 | 253 | 15 | 35 | 0 |
| 30 Sep 15 | 257 | 26 | 31 | 0 |
| 30 Jun 15 | 249 | 34 | 26 | 0 |
| 31 Mar 15 | 233 | 34 | 21 | 0 |
| 31 Dec 14 | 207 | 30 | 19 | 0 |
| 30 Sep 14 | 208 | 33 | 18 | 0 |
| 30 Jun 14 | 197 | 27 | 16 | 0 |
| 31 Mar 14 | 182 | 24 | 12 | 0 |
| 31 Dec 13 | 193 | 17 | 11 | 0 |
| 30 Sep 13 | 161 | 6 | 10 | 0 |
| 30 Jun 13 | 169 | 5 | 10 | 0 |
Quality Earnings: 6108 is currently unprofitable.
Growing Profit Margin: 6108 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6108 is unprofitable, and losses have increased over the past 5 years at a rate of 23% per year.
Accelerating Growth: Unable to compare 6108's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6108 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.8%).
Return on Equity
High ROE: 6108 has a negative Return on Equity (-4.62%), as it is currently unprofitable.